Free Trial

10 Best Small Cap Stocks to Buy Now - 10 of 10

 
 

MiMedx Group (NASDAQ:MDXG)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$12.00 (27.3% Upside)

About MiMedx Group

MiMedx Group logoMiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/1/2024Craig HallumLower Price TargetBuy ➝ Buy$14.00 ➝ $12.00
8/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$11.00 ➝ $11.00
7/2/2024Cantor FitzgeraldInitiated CoverageOverweight$11.00
5/1/2024HC WainwrightReiterated RatingBuy ➝ Buy$11.00
3/7/2024Lake Street CapitalInitiated CoverageBuy$12.00
3/1/2024MizuhoBoost Price TargetBuy ➝ Buy$13.00 ➝ $14.00
10/31/2023MizuhoLower Price TargetBuy ➝ Buy$14.00 ➝ $12.00
10/27/2023Craig HallumInitiated CoverageBuy$12.00
8/9/2023MizuhoBoost Price Target$12.00 ➝ $14.00
8/2/2023MizuhoBoost Price TargetBuy ➝ Buy$10.00 ➝ $12.00

More Investing Slideshows:

 

The latest trend in real estate (Ad)

These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.

Don’t miss your chance to maximize your stake in this co-ownership revolution.